Tango Therapeutics, Inc. · NASDAQ:TNGX
Adage Capital Management, L.P.'s stake in Tango Therapeutics, Inc. fell to 3.44% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 12, 2026
Adage Capital Management, L.P.'s stake in Tango Therapeutics, Inc. fell to 3.44%, 5,600,000 shares, as a passive investor on Jun 30, 2026. Filed Aug 12, 2026 (Schedule 13G/A).
- Stake
- 3.44%
- Shares
- 5,600,000
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Adage Capital Management, L.P. | 3.44% | 5,600,000 |
| Robert Atchinson | 3.44% | 5,600,000 |
| Phillip Gross | 3.44% | 5,600,000 |
Source
Related
- Tango Therapeutics, Inc.
- Adage Capital Management, L.P.
- Tango Therapeutics, Inc. shareholders
- Schedule 13G/A · Adage Capital Management, L.P. · May 13, 2026
- Schedule 13G · Adage Capital Management, L.P. · Feb 12, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Nov 13, 2025
- Schedule 13G · Adage Capital Management, L.P. · Aug 12, 2025
- Form 4 · Crystal Adam · Oct 5, 2026
- Form 4 · Newcomb Jessica · Sep 24, 2026
- Form 4 · Crystal Adam · Sep 3, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G · Goldman Sachs Group Inc · Aug 14, 2026